arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

COLLEGIUM PHARMACEUTICAL, INC

COLL
$29.48 ▲ +0.36 (+1.22%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
51 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
80
Health
Good
Bullish
auto_awesome

Analytical Summary

COLLEGIUM PHARMACEUTICAL, INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $945.9M
Dividend Yield
Revenue Growth 8.9%
Op. Margin 16.0%
ROIC 7.6%
FCF / Share $1.77
Trailing P/E 65.5x
Price / Book 3.1x
FCF Yield 6.0%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$193.52M
↑ +8.9%
Net Income Profit after all expenses
$14.50M
↑ +499.8%
Operating Margin Operating profit as % of sales
16.0%
↓ -46.0% 79th
FCF / Share Free cash flow per share
$1.77
↑ +3.2%
Long-Term Debt Long-term obligations
$11.50M
— 0.0%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
78
Returns
87
Financial Health
63
Cash Quality
95

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 51 quarters